Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Janus Kinase Inhibition in Granuloma AnnulareActive Not Recruiting
NCT05650736Phase 2Updated Mar 4, 2025
Sponsor: William Damsky
Granuloma Annulare
United States
Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative ColitisCompleted
NCT04505410Phase 3Updated Feb 28, 2025
Sponsor: University of Miami
Ulcerative Colitis
United States
A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.Terminated
NCT04543357N/AUpdated Feb 26, 2025
Sponsor: Pfizer
Household Contacts
United States
A Study Of PF-04449913 In Japanese Patients With Select Hematologic MalignanciesCompleted
NCT02038777Phase 1Updated Feb 26, 2025
Sponsor: Pfizer
Acute Myeloid Leukemia
Japan
A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.Completed
NCT05987072Phase 1Updated Feb 24, 2025
Sponsor: Pfizer
Respiratory Syncytial Virus Infection
China
A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese ParticipantsCompleted
NCT05371652Phase 3Updated Feb 20, 2025
Sponsor: Pfizer
Acute Migraine
China
Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction TherapyCompleted
NCT03839446Phase 2Updated Feb 20, 2025
Sponsor: Robert Redner, MD
Acute Myeloid Leukemia
United States
A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.Completed
NCT06586216Phase 1Updated Feb 19, 2025
Sponsor: Pfizer
COVID-19
United States
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma PatientsRecruiting
NCT02622581N/AUpdated Feb 18, 2025
Sponsor: AIO-Studien-gGmbH
Metastatic Non-small Cell Lung Cancer (NSCLC) · Non-small Cell Lung Cancer Metastatic · Non-small Cell Lung Cancer Stage II · Non Small Cell Lung Cancer Stage III
Germany
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone MetastasisCompleted
NCT03691493Phase 2Updated Feb 17, 2025
Sponsor: Emory University
Anatomic Stage IV Breast Cancer AJCC v8 · Estrogen Receptor Positive · HER2/Neu Negative · Metastatic Breast Carcinoma
United States
Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line TherapyTerminated
NCT03013946Phase 3Updated Feb 14, 2025
Sponsor: AIO-Studien-gGmbH
Renal Cell Carcinoma, Metastatic · Renal Cell Cancer, Recurrent
Germany
Sunitinib and Capecitabine for First Line Colon CancerTerminated
NCT00961571Phase 2Updated Feb 12, 2025
Sponsor: Georgetown University
Metastatic Colorectal Cancer
United States
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.Completed
NCT04424316Phase 3Updated Feb 11, 2025
Sponsor: Pfizer
Respiratory Tract Infection
United States, Argentina, Australia, Brazil, Canada +13 more
A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy ParticipantsCompleted
NCT05956002Phase 1Updated Feb 10, 2025
Sponsor: Pfizer
Healthy Participants
Belgium
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.Withdrawn
NCT06075615N/AUpdated Feb 7, 2025
Sponsor: Pfizer
Carcinoma, Non-Small-Cell Lung
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent StudyCompleted
NCT05192200Phase 2Updated Feb 6, 2025
Sponsor: Pfizer
Dermatomyositis
United States, Hungary, Poland, Spain
Rituximab + Immunotherapy in Follicular LymphomaTerminated
NCT03636503Phase 1Updated Feb 6, 2025
Sponsor: Dana-Farber Cancer Institute
Follicular Lymphoma
United States
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 InhibitorCompleted
NCT03854903Phase 1Updated Feb 6, 2025
Sponsor: Georgetown University
Metastatic Breast Cancer · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast · Hormone Receptor Positive Breast Cancer
United States
TITRATE (inducTIon for acuTe ulceRATivE Colitis)Terminated
NCT03937609Phase 4Updated Feb 6, 2025
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Colitis, Ulcerative
Ireland, Netherlands, Norway
Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In ColombiaCompleted
NCT04234698N/AUpdated Feb 6, 2025
Sponsor: Pfizer
Atrial Fibrillation
Colombia
A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial SettingsCompleted
NCT05954546N/AUpdated Feb 5, 2025
Sponsor: Pfizer
Metastatic Melanoma
United States
Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)No Longer Available
NCT05238311N/AUpdated Feb 4, 2025
Sponsor: Pfizer
Multiple Myeloma
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last TreatmentCompleted
NCT05597085N/AUpdated Feb 4, 2025
Sponsor: Pfizer
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
India
Long-term Safety of Tafamidis in Subjects With Transthyretin CardiomyopathyCompleted
NCT02791230Phase 3Updated Feb 3, 2025
Sponsor: Pfizer
Transthyretin (TTR) Amyloid Cardiomyopathy
United States, Argentina, Australia, Belgium, Brazil +12 more
A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy AdultsCompleted
NCT06646042Phase 1Updated Feb 3, 2025
Sponsor: Pfizer
Healthy
United States

Previous page Next page